The same in other media
U.S. FDA warns against using malaria drug on COVID-19 patients outside hospitals
Reading now: 672
The U.S. Food and Drug Administration on Friday cautioned against the use of malaria drugs, hydroxychloroquine and chloroquine, in COVID-19 patients outside of hospitals and clinical trials, citing risks of serious heart rhythm problems.
The agency’s announcement comes a day after the European Union’s drug regulator warned of the drugs’ side effects and urged medical professionals to closely monitor patients on the medicines.
The FDA said it was aware of increased use of these medicines through outpatient prescriptions and the drugs could cause abnormal heart rhythms and dangerously rapid heart rate.
Decades-old hydroxychloroquine has been touted by U.S. President Donald Trump as a “game changer” in the fight against the novel coronavirus
Read more on globalnews.ca
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.
COVID-19
United States
|
Cases: 46 252 513
Deaths: 750 423
Recovered: 0
|
India
|
Cases: 34 321 025
Deaths: 459 652
Recovered: 0
|
Brazil
|
Cases: 21 835 785
Deaths: 608 235
Recovered: 0
|
United Kingdom
|
Cases: 9 215 683
Deaths: 141 607
Recovered: 0
|
Russia
|
Cases: 8 494 589
Deaths: 237 619
Recovered: 0
|
